Shinobi Therapeutics
shinobitx.comShinobi Therapeutics is developing a new class of hypoimmune CD8ab iPS-T cells for cancer and beyond by using immune evasion to unlock the full potential of iPSCs.
Something looks off?Open jobs at Shinobi Therapeutics
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.